| Dec'19 | Dec'18 | Dec'17 | Dec'16 | |||
|---|---|---|---|---|---|---|
Cash flows from operating activities: | ||||||
Net income | ||||||
1,556 | 1,058 | -186 | 171 | |||
Adjustments to reconcile net income to net cash provided by operating activities: | ||||||
Provision for loan losses | ||||||
201 | 513 | 419 | 844 | |||
Depreciation | ||||||
346 | 342 | 460 | 473 | |||
Gain on sale of premises and equipment | ||||||
- | - | -64 | - | |||
Net accretion of loan portfolio discount and deposit premium | ||||||
113 | 144 | 405 | 438 | |||
Net amortization on securities available for sale | ||||||
-357 | -526 | -525 | -543 | |||
(Gain) loss on sales and impairments of foreclosed assets | ||||||
7 | -17 | 12 | 4 | |||
Loss on sale of available for sale securities | ||||||
-4 | -204 | 20 | - | |||
Gain on sale of available for sale securities | ||||||
- | - | - | 129 | |||
Increase in cash surrender value of life insurance | ||||||
218 | 194 | 196 | 198 | |||
Accretion of discount on FHLB advances | ||||||
- | - | 27 | 27 | |||
ESOP compensation | ||||||
138 | 143 | 32 | - | |||
Stock based compensation | ||||||
338 | 18 | - | - | |||
Changes in operating assets and liabilities: | ||||||
Accrued interest receivable | ||||||
-43 | -14 | 22 | -46 | |||
Loans held for sale | ||||||
-479 | 570 | -483 | -44 | |||
Other assets | ||||||
579 | -42 | -366 | -20 | |||
Accrued interest payable | ||||||
-19 | 33 | 8 | 1 | |||
Other liabilities | ||||||
215 | 28 | -323 | 645 | |||
Net cash provided by operating activities | ||||||
- | - | - | 1,999 | |||
Net cash provided by operating activities | ||||||
2,741 | 2,030 | 1,166 | - | |||
Cash flows from investing activities: | ||||||
Proceeds from sales of available for sale securities | ||||||
4,836 | 12,874 | - | - | |||
Proceeds from sales of available for sale securities | ||||||
- | - | 6,856 | 9,485 | |||
Maturities, calls, paydowns on available for sale securities | ||||||
7,327 | 8,091 | 8,081 | 11,789 | |||
Purchases of available for sale securities | ||||||
15,669 | 7,867 | - | - | |||
Purchases of available for sale securities | ||||||
- | - | 25,029 | 21,903 | |||
Net (increase) decrease in loans | ||||||
-9,231 | 27,967 | 5,793 | -4,011 | |||
Purchases of premises and equipment | ||||||
96 | 109 | 357 | 99 | |||
Proceeds from redemption of FHLB stock | ||||||
165 | - | 833 | - | |||
Purchase of FHLB stock | ||||||
- | 225 | - | - | |||
Purchase of Bankers' Bank stock | ||||||
206 | - | - | - | |||
Proceeds from redemption of life insurance | ||||||
161 | - | - | - | |||
Proceeds from sale of equipment | ||||||
- | - | 2,153 | 25 | |||
Purchase of life insurance | ||||||
4 | 255 | 10 | - | |||
Proceeds from sale of foreclosed assets | ||||||
76 | 792 | 1,458 | 86 | |||
Net cash (used) provided by investing activities | ||||||
- | - | - | 3,394 | |||
Net cash provided by (used in) investing activities | ||||||
5,821 | -14,666 | -11,808 | - | |||
Cash flows from financing activities: | ||||||
Net increase in deposits | ||||||
34,047 | 292 | -1,726 | 433 | |||
Net (decrease) increase in escrow | ||||||
-9 | 19 | 3 | -8 | |||
Net decrease in FHLB open line of credit | ||||||
- | - | 2,500 | 1,500 | |||
Repayments of FHLB advances | ||||||
7,750 | 2,000 | 6,000 | 5,000 | |||
Proceeds from FHLB advances | ||||||
1,500 | 7,000 | - | 4,500 | |||
Repurchase of common stock | ||||||
1,461 | - | - | - | |||
Net proceeds from issuance of common stock | ||||||
- | - | 25,767 | - | |||
Net cash (used) provided in financing activities | ||||||
- | - | - | -1,575 | |||
Net cash provided by financing activities | ||||||
26,327 | 5,311 | 15,544 | - | |||
Net increase (decrease) in cash and cash equivalents | ||||||
34,889 | -7,325 | 4,902 | 3,818 | |||
Supplemental Cash Flow Disclosures: | ||||||
Cash paid for interest | ||||||
2,807 | 2,076 | 1,546 | - | |||
Cash paid for interest | ||||||
- | - | - | 1,632 | |||
Cash paid for income taxes | ||||||
415 | 120 | - | 20 | |||
Loans transferred to foreclosed assets | ||||||
84 | 238 | 1,118 | 757 | |||
Financed sales of foreclosed assets | ||||||
- | 21 | 280 | - | |||